Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Organic Letters|December 14, 2011
Functionally diverse nucleophilic trapping of iminium intermediates generated utilizing visible lightDavid B Freeman, Laura Furst, Allison G Condie, et al.Plos Currents|February 6, 2018
Epidemiological Review of Francisella Tularensis: A Case Study in the Complications of Dual DiagnosesRalph Anthony Stidham, David B Freeman, Robert L von Tersch, et al.Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists|March 14, 2007
The relation between symptom validity testing and MMPI-2 scores as a function of forensic evaluation contextDustin B Wygant, Martin Sellbom, Yossef S Ben-Porath, et al.Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists|October 3, 2009
Examination of the MMPI-2 restructured form (MMPI-2-RF) validity scales in civil forensic settings: findings from simulation and known group samplesDustin B Wygant, Yossef S Ben-Porath, Paul A Arbisi, et al.Psychological Assessment|October 6, 2010
Further validation of the MMPI-2 and MMPI-2-RF Response Bias Scale: findings from disability and criminal forensic settingsDustin B Wygant, Martin Sellbom, Roger O Gervais, et al.Tetrahedron|August 25, 2010
Welwitindolinone C synthetic studies. Construction of the welwitindolinone carbon skeleton via a transannular nitrone cycloadditionDavid B Freeman, Alexandra A Holubec, Matthew W Weiss, et al.Journal of Medicinal Chemistry|November 15, 2023
Discovery of KB-0742, a Potent, Selective, Orally Bioavailable Small Molecule Inhibitor of CDK9 for MYC-Dependent CancersDavid B Freeman, Tamara D Hopkins, Peter J Mikochik, et al.Cell Chemical Biology|March 19, 2019
Stabilization of the Max Homodimer with a Small Molecule Attenuates Myc-Driven TranscriptionNicholas B Struntz, Andrew Chen, Anja Deutzmann, et al.Cell Chemical Biology|October 21, 2020
Modulating Androgen Receptor-Driven Transcription in Prostate Cancer with Selective CDK9 InhibitorsAndré Richters, Shelby K Doyle, David B Freeman, et al.Pageof 1